Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial

Detalles Bibliográficos
Autores principales: Cosentino, Francesco, Cannon, Christopher P., Frederich, Robert, Cherney, David Z.I., Dagogo-Jack, Samuel, Pratley, Richard E., Mancuso, James P., Maldonado, Mario, Cater, Nilo B., Wang, Shuai, McGuire, Darren K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390228/
https://www.ncbi.nlm.nih.gov/pubmed/35994565
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.058294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390228/
https://www.ncbi.nlm.nih.gov/pubmed/35994565
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.058294

Ejemplares similares